Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Jan Prasko,1 Marie Ociskova,1 Ales Grambal,1 Zuzana Sigmundova,1 Petra Kasalova,1 Marketa Marackova,1 Michaela Holubova,1,2 Kristyna Vrbova,1 Klara Latalova,1 Milos Slepecky3 1Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomou...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Depressive disorder / cognitive-behavioral therapy / pharmacotherapy / psychodynamic therapy / treatment efficacy / dissociation / personality features / hope / self-stigma Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ffe0fa1e91a045feb73f11e97d84029b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ffe0fa1e91a045feb73f11e97d84029b
record_format	dspace
spelling	oai:doaj.org-article:ffe0fa1e91a045feb73f11e97d84029b2021-12-02T07:12:21ZPersonality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder1178-2021https://doaj.org/article/ffe0fa1e91a045feb73f11e97d84029b2016-10-01T00:00:00Zhttps://www.dovepress.com/personality-features-dissociation-self-stigma-hope-and-the-complex-tre-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Jan Prasko,1 Marie Ociskova,1 Ales Grambal,1 Zuzana Sigmundova,1 Petra Kasalova,1 Marketa Marackova,1 Michaela Holubova,1,2 Kristyna Vrbova,1 Klara Latalova,1 Milos Slepecky3 1Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, 2Department of Psychiatry, Hospital Liberec, Liberec, Czech Republic; 3Department of Psychology Sciences, Faculty of Social Science and Health Care, Constantine the Philosopher University in Nitra, Nitra, Slovak Republic Objective: Identifying the predictors of response to psychiatric and psychotherapeutic treatments may be useful for increasing treatment efficacy in pharmacoresistant depressive patients. The goal of this study was to examine the influence of dissociation, hope, personality trait, and selected demographic factors in treatment response of this group of patients.Methods: Pharmacoresistant depressive inpatients were enrolled in the study. All patients completed Clinical Global Impression – both objective and subjective form (CGI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) at baseline and after 6 weeks of combined pharmacotherapy and psychotherapy (group cognitive-behavioral or group psychodynamic) treatment as an outcome measures. The Internalized Stigma of Mental Illness Scale (ISMI), Dissociative Experience Scale (DES), Adult Dispositional Hope Scale (ADHS), and Temperament and Character Inventory (TCI-R) were completed at the start of the treatment with the intention to find the predictors of treatment efficacy.Results: The study included 72 patients who were hospitalized for the pharmacoresistant major depression; 63 of them completed the study. The mean scores of BDI-II, BAI, subjCGI, and objCGI significantly decreased during the treatment. BDI-II relative change statistically significantly correlated with the total ISMI score, Discrimination Experience (ISMI subscale), and Harm Avoidance (TCI-R personality trait). According to stepwise regression, the strongest factors connected to BDI-II relative change were the duration of the disorder and Discrimination Experience (domain of ISMI). ObjCGI relative change significantly correlated with the level of dissociation (DES), the total ISMI score, hope in ADHS total score, and Self-Directedness (TCI-R). According to stepwise regression, the strongest factor connected to objCGI relative change was Discrimination Experience (domain of ISMI). The existence of comorbid personality disorder did not influence the treatment response.Conclusion: According to the results of the present study, patients with pharmacoresistant depressive disorders, who have had more experience with discrimination because of their mental struggles, showed a poorer response to treatment. Keywords: depressive disorder, cognitive-behavioral therapy, pharmacotherapy, psychodynamic therapy, treatment efficacy, dissociation, personality features, hope, self-stigmaPrasko JOciskova MGrambal ASigmundova ZKasalova PMarackova MHolubova MVrbova KLatalova KSlepecky MDove Medical PressarticleDepressive disorder / cognitive-behavioral therapy / pharmacotherapy / psychodynamic therapy / treatment efficacy / dissociation / personality features / hope / self-stigmaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2539-2552 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Depressive disorder / cognitive-behavioral therapy / pharmacotherapy / psychodynamic therapy / treatment efficacy / dissociation / personality features / hope / self-stigma Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Depressive disorder / cognitive-behavioral therapy / pharmacotherapy / psychodynamic therapy / treatment efficacy / dissociation / personality features / hope / self-stigma Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Prasko J Ociskova M Grambal A Sigmundova Z Kasalova P Marackova M Holubova M Vrbova K Latalova K Slepecky M Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
description	Jan Prasko,1 Marie Ociskova,1 Ales Grambal,1 Zuzana Sigmundova,1 Petra Kasalova,1 Marketa Marackova,1 Michaela Holubova,1,2 Kristyna Vrbova,1 Klara Latalova,1 Milos Slepecky3 1Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, 2Department of Psychiatry, Hospital Liberec, Liberec, Czech Republic; 3Department of Psychology Sciences, Faculty of Social Science and Health Care, Constantine the Philosopher University in Nitra, Nitra, Slovak Republic Objective: Identifying the predictors of response to psychiatric and psychotherapeutic treatments may be useful for increasing treatment efficacy in pharmacoresistant depressive patients. The goal of this study was to examine the influence of dissociation, hope, personality trait, and selected demographic factors in treatment response of this group of patients.Methods: Pharmacoresistant depressive inpatients were enrolled in the study. All patients completed Clinical Global Impression – both objective and subjective form (CGI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) at baseline and after 6 weeks of combined pharmacotherapy and psychotherapy (group cognitive-behavioral or group psychodynamic) treatment as an outcome measures. The Internalized Stigma of Mental Illness Scale (ISMI), Dissociative Experience Scale (DES), Adult Dispositional Hope Scale (ADHS), and Temperament and Character Inventory (TCI-R) were completed at the start of the treatment with the intention to find the predictors of treatment efficacy.Results: The study included 72 patients who were hospitalized for the pharmacoresistant major depression; 63 of them completed the study. The mean scores of BDI-II, BAI, subjCGI, and objCGI significantly decreased during the treatment. BDI-II relative change statistically significantly correlated with the total ISMI score, Discrimination Experience (ISMI subscale), and Harm Avoidance (TCI-R personality trait). According to stepwise regression, the strongest factors connected to BDI-II relative change were the duration of the disorder and Discrimination Experience (domain of ISMI). ObjCGI relative change significantly correlated with the level of dissociation (DES), the total ISMI score, hope in ADHS total score, and Self-Directedness (TCI-R). According to stepwise regression, the strongest factor connected to objCGI relative change was Discrimination Experience (domain of ISMI). The existence of comorbid personality disorder did not influence the treatment response.Conclusion: According to the results of the present study, patients with pharmacoresistant depressive disorders, who have had more experience with discrimination because of their mental struggles, showed a poorer response to treatment. Keywords: depressive disorder, cognitive-behavioral therapy, pharmacotherapy, psychodynamic therapy, treatment efficacy, dissociation, personality features, hope, self-stigma
format	article
author	Prasko J Ociskova M Grambal A Sigmundova Z Kasalova P Marackova M Holubova M Vrbova K Latalova K Slepecky M
author_facet	Prasko J Ociskova M Grambal A Sigmundova Z Kasalova P Marackova M Holubova M Vrbova K Latalova K Slepecky M
author_sort	Prasko J
title	Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
title_short	Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
title_full	Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
title_fullStr	Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
title_full_unstemmed	Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
title_sort	personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/ffe0fa1e91a045feb73f11e97d84029b
work_keys_str_mv	AT praskoj personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT ociskovam personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT grambala personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT sigmundovaz personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT kasalovap personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT marackovam personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT holubovam personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT vrbovak personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT latalovak personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder AT slepeckym personalityfeaturesdissociationselfstigmahopeandthecomplextreatmentofdepressivedisorder
_version_	1718399613665280000

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Ejemplares similares